Articles

Videos

Podcasts

Clinical

The most common way to detect bacteria and determine the right medication to use is with the gram stain test, which will show whether the bacteria is gram-positive or gram-negative

An Overview of Antimicrobials in Pneumonia Pharmacotherapy

Pharmacists are in an excellent position to educate and counsel patients on current recommendations.

The Evolution of Pneumococcal Vaccines and Current Guidelines

Dalbavancin (Dalvance) is indicated for acute bacterial skin and skin structure infections caused by designated susceptible strains of Gram-positive microorganisms.

Daily Medication Pearl: Dalbavancin (Dalvance)

The investigational PCV is designed to target serotypes responsible for 85% of all invasive cases of the disease in individuals aged 65 and older in the United States.

Merck Announced Positive Study Results Evaluating V116 Pneumococcal Vaccine

Oritavancin (Orbactiv) is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms.

Daily Medication Pearl: Oritavancin (Orbactiv)

Vaxneuvance was approved for an expanded indication by the FDA on June 22, 2022, for active immunization in children 6 weeks of age and older.

ACIP Unanimously Recommends Use of Pneumococcal 15-Valent Conjugate Vaccine for Infants and Children

Vaxneuvance is now indicated for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older.

FDA Approves Expanded Indication for Vaxneuvance Pneumococcal Vaccine

New recommendations provide some harmonization to make it easier for clinicians to lower the barriers to assessing and identifying eligible patients for the pneumococcal vaccine.

2022 Updated CDC Recommendations for Pneumococcal Vaccination Lower Barriers to Assessing, Identifying Eligible Patients 

Expert emphasizes that it is important to acknowledge the critical role of pharmacists in overcoming barriers to vaccinations.

Expert: ‘Vaccination Is a Team Sport,’ Pharmacists Are Key Players

Ciprodex is approved for the treatment of ear infections, acute otitis media, and acute otitis externa.

Clinical Overview: Ciprofloxacin/Dexamethasone for Acute Otitis Media, Acute Otitis Externa

® Pneumococcal Resource Center is a comprehensive resource for clinical news and expert insights for any infection caused by the bacteria Streptococcus pneumoniae, or pneumococcus.